Novo A/S, the holding company for the companies in the Novo Group, is changing its name to Novo Holdings A/S.
The new name will more accurately reflect the company’s role and will help to re-duce any confusion with the other companies in the Novo Group.
In connection with the new name, Novo Holdings will add the tagline “Investors in life science”. This clarifies that the company is a life-science focused investor, in addition to being the holding company of the Novo Group.
Novo Holdings currently wholly or partly owns more than 80 life-science compa-nies, many of which are headquartered in the United States. Last year, the com-pany invested DKK 8.7 billion in the life sciences. The strategy of Novo Holdings is to substantially increase its investments in life-science companies over the coming years.